Track the 药明康德 share price and the full insider trade history of the company, a listed equity based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 药明康德 has published 23 reports. Market capitalisation: €374.4bn. The latest transaction was reported on 30 September 2021 (Sale). Among the most active insiders: Shuhui Chen(陈曙辉). The full history is free.
23
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€4m
23 ops.
Sell Volume
22Σ signal
Buys n/a€4m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 4,673 of 28,717 companies
69.2
score / 100
Value
54
Quality
84
FCF yld3.1%
Earn yld5.1%
EV/EBITDA13.8x
ROE26%
Gross mgn48%
Net mgn42%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
WuXi AppTec is a company specializing in research and development services for the pharmaceutical and biopharmaceutical industries. It is listed on the Shanghai Stock Exchange.